---
document_datetime: 2024-07-04 12:33:37
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/sotyktu-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: sotyktu-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.3277853
conversion_datetime: 2025-12-27 14:13:53.094026
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## SOTYKTU

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0011              | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) | 03/07/2024                          |                                             | SmPC                             |           |
| IA/0010              | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change                                   | 21/06/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                       |            |     |      |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|-----------------------------------|
| IA/0009/G           | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material | 28/05/2024 | n/a |      |                                   |
| IA/0007             | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                                                                                                                                                                                                                                                                      | 16/05/2024 |     | SmPC |                                   |
| IA/0006             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                         | 29/04/2024 | n/a |      |                                   |
| PSUSA/11046 /202309 | Periodic Safety Update EU Single assessment - deucravacitinib                                                                                                                                                                                                                                                                                                                                      | 11/04/2024 | n/a |      | PRAC Recommendation - maintenance |
| IA/0005/G           | This was an application for a group of variations. B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                        | 01/02/2024 | n/a |      |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0004   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation   | 25/01/2024   | n/a   |    |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|----|
| N/0003    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                | 20/12/2023   |       | PL |
| IB/0001   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                      | 10/10/2023   | n/a   |    |